Self-assembly drug conjugates for anticancer treatment

[Display omitted] •Many anticancer compounds are unable to demonstrate pharmacological activity because they do not reach therapeutic concentration at the site of action.•Nanotechnology is a useful tool to improve the selective delivery of anticancer compounds to their site of action.•An interesting...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Drug discovery today 2016-08, Vol.21 (8), p.1321-1329
Hauptverfasser:	Fumagalli, Gaia, Marucci, Cristina, Christodoulou, Michael S., Stella, Barbara, Dosio, Franco, Passarella, Daniele
Format:	Artikel
Sprache:	eng
Schlagworte:	Animals Antineoplastic Agents - administration & dosage Antineoplastic Agents - chemistry Antineoplastic Agents - pharmacology Antineoplastic Agents - therapeutic use Drug Delivery Systems Humans Nanoparticles - administration & dosage Nanoparticles - chemistry Nanoparticles - therapeutic use Neoplasms - drug therapy Prodrugs - administration & dosage Prodrugs - chemistry Prodrugs - pharmacology Prodrugs - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!